Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates

Infection and Immunity

Volumn 69, Issue 2, 2001, Pages 1142-1150

  Smith, D A ^a   Parish, T ^a   Stoker, N G ^a   Bancroft, G J ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE; PROLINE; TRYPTOPHAN; VACCINE;

AMINO ACID SYNTHESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUXOTROPHIC MUTANT; BACTERIAL VIRULENCE; CONTROLLED STUDY; GENE MUTATION; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; SCID MOUSE;

ANIMALS; BCG VACCINE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICE, SCID; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PROLINE; TRYPTOPHAN; VIRULENCE;

EID: 0035145539     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.69.2.1442-1150.2001     Document Type: Article

References (32)

1. Modulation of murine macrophage behaviour in vivo and in vitro
2. Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages
3. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
4. Virulence ranking of some Mycobacterium tuberculosis and Mycobacterium bovis strains according to their ability to multiply in the lungs, induce lung pathology, and cause mortality in mice
5. Global burden of tuberculosis. Estimated incidence, prevalence, and mortality by country
6. Organ-specific responses associated with infectious disease
7. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent
8. Variation in protection by BCG: Implications of and for heterologous immunity
9. What is BCG?
10. Auxotrophic vaccines for tuberculosis
11. Mechanisms of granuloma formation in murine Mycobacterium avium infection: The contribution of CD4+ T cells
12. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines
13. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis
14. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine
15. Intracellular replication is essential for the virulence of Salmonella typhimurium
16. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
17. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis
18. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype
19. Isolation and characterization of auxotrophic mutants of Legionella pneumophila that fail to multiply in human monocytes
20. Granuloma formation in severe combined immunodeficient (SCID) mice in response to progressive BCG infection. Tendency not to form granulomas in the lung is associated with faster bacterial growth in this organ
21. Mycobacterial virulence. Virulent strains of Mycobacterium tuberculosis have faster in vivo doubling times and are better equipped to resist growth-inhibiting functions of macrophages in the presence and absence of specific immunity
22. Characterization of aromatic and purine-dependent Salmonella typhimurium: Attenuation, persistence, and ability to induce protective immunity in BALB/c mice
23. Global surveillance for antituberculosis-drug resistance, 1994-1997
24. Production of mutants in amino acid biosynthesis genes of Mycobacterium tuberculosis by homologous recombination
25. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement
26. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis
27. Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis
28. T-cell-independent granuloma formation in response to Mycobacterium avium: Role of tumour necrosis factor-alpha and interferon-gamma
29. Differential identification of mycobacteria. Use of thiacetazone, thiophen-2-carboxylic acid hydrazide and tripheyltetrazolium chloride
30. A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: Three-year results
31. New vaccines against tuberculosis